StockClub

VRDN

VRDNViridian Therapeutics, Inc.$ --
Viridian Therapeutics, Inc.

Viridian Therapeutics, Inc.

VRDN

$ -

-

Review earnings summary, surprise history, and upcoming forecasts.

wallet
Earnings Summary
Updated: 03/31/2026FY2026 Q1
Revenue
0M USD
YoY +95.8%
Operating Income
-116M USD
YoY -23.8%
Net Income
-105M USD
YoY -20.7%
EPS
-60.02$
YoY -6798.9%

Revenue

$141,000
FY2024 Q2$144,000
$144,000
Q2
FY2024 Q3$230,000
$230,000
Q3
FY2024 Q4$302,000
$302,000
Q4
FY2025 Q1$72,000
$72,000
Q1
FY2025 Q2$147,000
$147,000
Q2
FY2025 Q3$70.7M
$70.7M
Q3
FY2025 Q4$70.8M
$70.8M
Q4
FY2026 Q1$141,000
$141,000
Q1
Actual
+$69,000 (+95.8%)

Net Income

$-104.9M
FY2024 Q2$-113.5M
$-113.5M
Q2
FY2024 Q3$-190.2M
$-190.2M
Q3
FY2024 Q4$-269.9M
$-269.9M
Q4
FY2025 Q1$-86.9M
$-86.9M
Q1
FY2025 Q2$-187.6M
$-187.6M
Q2
FY2025 Q3$-222.2M
$-222.2M
Q3
FY2025 Q4$-342.6M
$-342.6M
Q4
FY2026 Q1$-104.9M
$-104.9M
Q1
Actual
$-18M (-20.7%)

Surprise History

Actual RevenueAnalyst Estimate
FY2020BEAT
Actual:$1.1M
Est:$866,667
FY2020BEAT
$1.1M
FY2021MISS
Actual:$3M
Est:$3M
FY2021MISS
$3M
FY2022MISS
Actual:$1.8M
Est:$2.1M
FY2022MISS
$1.8M
FY2023BEAT
Actual:$314,000
Est:$288,000
FY2023BEAT
$314,000
FY2024MISS
Actual:$302,000
Est:$317,286
FY2024MISS
$302,000
FY2025MISS
Actual:$70.8M
Est:$85.4M
FY2025MISS
$70.8M

Analyst Estimates